1mue: Difference between revisions
Jump to navigation
Jump to search
m Protected "1mue" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1mue.png|left|200px]] | [[Image:1mue.png|left|200px]] | ||
{{STRUCTURE_1mue| PDB=1mue | SCENE= }} | {{STRUCTURE_1mue| PDB=1mue | SCENE= }} | ||
===Thrombin-Hirugen-L405,426=== | ===Thrombin-Hirugen-L405,426=== | ||
{{ABSTRACT_PUBMED_12657281}} | {{ABSTRACT_PUBMED_12657281}} | ||
==About this Structure== | ==About this Structure== | ||
[[1mue]] is a 3 chain structure of [[Hirudin]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MUE OCA]. | [[1mue]] is a 3 chain structure of [[Hirudin]] and [[Thrombin]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MUE OCA]. | ||
==See Also== | ==See Also== | ||
*[[Hirudin]] | *[[Hirudin|Hirudin]] | ||
*[[Thrombin|Thrombin]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:012657281</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Thrombin]] | [[Category: Thrombin]] | ||
| Line 59: | Line 49: | ||
[[Category: Yan, Y.]] | [[Category: Yan, Y.]] | ||
[[Category: Alpha thrombin-hirugen]] | [[Category: Alpha thrombin-hirugen]] | ||
[[Category: Hydrolase | [[Category: Blood clotting complex]] | ||
[[Category: Hydrolase inhibitor]] | |||
[[Category: Hydrolase inhibitor complex]] | |||
Revision as of 09:33, 27 July 2012
Thrombin-Hirugen-L405,426Thrombin-Hirugen-L405,426
Template:ABSTRACT PUBMED 12657281
About this StructureAbout this Structure
1mue is a 3 chain structure of Hirudin and Thrombin with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Burgey CS, Robinson KA, Lyle TA, Nantermet PG, Selnick HG, Isaacs RC, Lewis SD, Lucas BJ, Krueger JA, Singh R, Miller-Stein C, White RB, Wong B, Lyle EA, Stranieri MT, Cook JJ, McMasters DR, Pellicore JM, Pal S, Wallace AA, Clayton FC, Bohn D, Welsh DC, Lynch JJ Jr, Yan Y, Chen Z, Kuo L, Gardell SJ, Shafer JA, Vacca JP. Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 N-benzylamides. Bioorg Med Chem Lett. 2003 Apr 7;13(7):1353-7. PMID:12657281
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCACategories:
- Pages with broken file links
- Homo sapiens
- Thrombin
- Bohn, D.
- Burgey, C S.
- Chen, Z.
- Clayton, F C.
- Cook, J J.
- Gardell, S J.
- Isaacs, R C.
- Krueger, J A.
- Kuo, L.
- Lewis, S D.
- Lucas, B J.
- Lyle, E A.
- Lyle, T A.
- Lynch, J J.
- McMasters, D R.
- Miller-Stein, C.
- Nantermet, P G.
- Pal, S.
- Pellicore, J M.
- Robinson, K A.
- Selnick, H G.
- Shafer, J A.
- Singh, R.
- Stranieri, M T.
- Vacca, J P.
- Wallace, A A.
- Welsh, D C.
- White, R B.
- Wong, B.
- Yan, Y.
- Alpha thrombin-hirugen
- Blood clotting complex
- Hydrolase inhibitor
- Hydrolase inhibitor complex